Invention Grant
- Patent Title: Pharmaceutical composition for use in the treatment of glaucoma
- Patent Title (中): 药物组合物用于治疗青光眼
-
Application No.: US13807355Application Date: 2011-06-24
-
Publication No.: US09095591B2Publication Date: 2015-08-04
- Inventor: William Rostene , Alexandre Denoyer , Christophe Baudouin , David Godefroy
- Applicant: William Rostene , Alexandre Denoyer , Christophe Baudouin , David Godefroy
- Applicant Address: FR Paris
- Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
- Current Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
- Current Assignee Address: FR Paris
- Agency: Whitham, Curtis, Christofferson & Cook, P.C.
- Priority: EP10305693 20100628
- International Application: PCT/EP2011/060638 WO 20110624
- International Announcement: WO2012/000904 WO 20120105
- Main IPC: A01N43/90
- IPC: A01N43/90 ; A61K31/519
Abstract:
The present invention relates to a compound which is an antagonist of CXCR3 or an inhibitor of the CXCR3 receptor expression for the treatment of glaucoma.
Public/Granted literature
- US20130172370A1 PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF GLAUCOMA Public/Granted day:2013-07-04
Information query
IPC分类:
